Thank you, Mr. Chair, and honourable member.
TRIUMF has a long history of working and developing medical isotopes that stretches back to the founding of the lab some 35 years ago. This new facility, ARIEL, will allow the laboratory to expand that program by developing new medical isotopes that which will enable new types of diagnostic procedures to occur, and therapeutic treatments as well.
One can imagine taking the radioactive isotopes and delivering them to cancer cells where they will kill those cells.
So what the laboratory will be doing is embarking on a new research area with focus on the health of Canadians.